Skip to main content
. 2011 Jan 6;286(11):9268–9279. doi: 10.1074/jbc.M110.179903

FIGURE 4.

FIGURE 4.

The TACE inhibitor TAPI-1 prevents TNF-α-induced ERK and RhoA activation. LLC-PK1 cells were treated for 15 min with 10 μm TAPI-1 before the addition of TNF-α or EGF (10 ng/ml, 10 min). pERK (A) or active RhoA (B) levels were detected and quantified as described earlier. In A the maximal effect (EGF-induced pERK) was taken as 100%, as the control (untreated) values in some experiments were too close to the background.